| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.9M | — | +156.4% |
| Cost of Revenue | $17.1M | — | +367.2% |
| Gross Profit | $4.8M | — | -1.8% |
| R&D Expense | $2.6M | — | -32.3% |
| SG&A Expense | $21.2M | — | +21.3% |
| Operating Income | -$24.2M | — | -15.8% |
| Pre-tax Income | -$32.5M | — | -56.2% |
| Income Tax | $1K | — | -99.7% |
| Net Income | -$32.5M | — | -53.7% |
| EPS (Basic) | -$0.20 | — | -42.9% |
| EPS (Diluted) | -$0.20 | — | -42.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $55.2M | -5.2% | +210.0% |
| Short-term Investments | $333K | +2.5% | -90.0% |
| Accounts Receivable | $4.9M | -81.0% | +23.5% |
| Inventory | $126K | -9.4% | +17.8% |
| Current Assets | $103.8M | -14.3% | +39.6% |
| Total Assets | $298.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$53.8M | — | -1870.6% |
| Capital Expenditures | $7.1M | — | +4.1% |
| Investing Cash Flow | $4.7M | — | +164.4% |
| Financing Cash Flow | $61.2M | — | +126.0% |
| Free Cash Flow | -$60.9M | — | -539.7% |
| +37.1% |
| Current Liabilities | $72.0M | -56.3% | -16.5% |
| Long-term Debt | $150.5M | +296.4% | +1068.0% |
| Total Liabilities | $244.3M | +8.9% | +138.2% |
| Stockholders' Equity | $30.5M | -54.9% | -73.5% |